2B70:F:F-iShares NASDAQ US Biotechnology UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.9

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-25 )

ETFs Containing 2B70:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.55% 43% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.55% 41% F 48% F
Trailing 12 Months  
Capital Gain 8.24% 49% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.24% 46% F 51% F
Trailing 5 Years  
Capital Gain 41.62% 61% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.62% 61% D- 51% F
Average Annual (5 Year Horizon)  
Capital Gain 6.32% 67% D+ 66% D+
Dividend Return 6.32% 66% D+ 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.50% 42% F 72% C
Risk Adjusted Return 43.60% 64% D 70% C-
Market Capitalization 0.52B 62% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.